Get the Stockscreener App
10.05
0.10%
0.01
After Hours:
10.05
908 Devices Inc stock is traded at $10.05, with a volume of 201.07K.
It is up +0.10% in the last 24 hours and up +18.93% over the past month.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
See More
Previous Close:
$10.04
Open:
$10.02
24h Volume:
201.07K
Relative Volume:
0.53
Market Cap:
$415.40M
Revenue:
$57.80M
Net Income/Loss:
$-35.29M
P/E Ratio:
-10.06
EPS:
-0.9987
Net Cash Flow:
$-8.42M
1W Performance:
-6.34%
1M Performance:
+18.93%
6M Performance:
+49.11%
1Y Performance:
+82.73%
1-Day Range:
$9.87
$10.12
1-Week Range:
$9.79
$11.00
52-Week Range:
$5.025
$11.25
908 Devices Inc Stock (MASS) Company Profile
Name
908 Devices Inc
Sector
Industry
Phone
978-729-4478
Address
44 THIRD AVENUE, BURLINGTON
Compare MASS vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
10.05 | 427.80M | 57.80M | -35.29M | -8.42M | -0.9987 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-13-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-07-23 | Initiated | Stephens | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jan-12-21 | Initiated | Cowen | Outperform |
| Jan-12-21 | Initiated | SVB Leerink | Outperform |
| Jan-12-21 | Initiated | Stifel | Buy |
| Jan-12-21 | Initiated | William Blair | Outperform |
View All
908 Devices Inc Stock (MASS) Latest News
908 Devices: director Brown sells $317,400 of common stock By Investing.com - Investing.com Canada
908 Devices: director Brown sells $317,400 of common stock - Investing.com
Director at 908 Devices (NASDAQ: MASS) sells 30,000 shares under 10b5-1 plan - Stock Titan
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium - Business Wire
908 Devices Inc. (MASS) Presents at 17th Annual Midwest IDEAS ConferenceSlideshow - Seeking Alpha
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates - Yahoo Finance
908 Devices Inc (NASDAQ: MASS) Share Price, MASS Stock News, MASS Share Price & Updates - Kalkine
908 Devices (MASS) CFO sells shares under 10b5-1 plan - Stock Titan
908 Devices CFO Joseph H. Griffith IV disposes of 11,459 common shares worth $125,476.05 - Bitget
A Look at 908 Devices Inc (MASS) After 5.7% Decline -- GF Value $7.06 vs Price $10.35 - GuruFocus
908 Devices at Midwest IDEAS Conference: focus narrows, margins improve By Investing.com - Investing.com Canada
908 Devices (MASS) officer plans $125K stock sale - Stock Titan
AWM trims 50,000-share stake in 908 Devices Inc. (MASS) stock - Stock Titan
Is 908 Devices Inc (MASS) Overvalued After 3.3% Rally? GF Value - GuruFocus
908 Devices (MASS) Q2 2026 Earnings Call Transcript - AOL.com
908 Devices (NASDAQ:MASS) Qualifies for Minervini Trend Template and High-Growth Momentum Screen - ChartMill
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection - TradingView
908 Devices (MASS) Rises 1.80% as Shares Approach Key Resistance at $10.70Hidden Order - vinanet.vn
908 Devices CEO Knopp sells $283,677 in common stock - Investing.com
908 Devices CEO Knopp sells $283,677 in common stock By Investing.com - Investing.com India
908 Devices (MASS) CEO offloads 27K shares under preset 10b5-1 plan - Stock Titan
MASS Q2 2026 Earnings: Narrowed Loss Beats Estimates by 36.6%, Shares Tick HigherAnalyst Earnings Estimate - vinanet.vn
908 Devices (NASDAQ: MASS) founder lines up new stock sale - Stock Titan
908 devices director Christopher Brown sells $169,800 in shares By Investing.com - Investing.com Canada
908 devices director Christopher Brown sells $169,800 in shares - Investing.com
Dimensional Fund Advisors LP Has $726,000 Stake in 908 Devices Inc. $MASS - MarketBeat
908 Devices (MASS) Slips to $10.01, Testing Support Amid Sideways DriftBPI Bull Correction - vinanet.vn
MASS|908 Devices Inc.|Price:10.010|Chg%:-0.100 - TradingKey
908 Devices Inc. (MASS) Stock News Today - TradingKey
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market - MarketBeat
908 Devices Stock Price Forecast. Should You Buy MASS? - StockInvest.us
ARCH funds disclose 13.9% ownership of 908 Devices Inc. (MASS) in latest 13G/A - Stock Titan
ARK Investment Management (MASS) reports 2.0M-share, 5.32% holding in 908 Devices - Stock Titan
AWM Investment Company reports 11.8% 908 Devices (MASS) ownership through Special Situations funds - Stock Titan
908 Devices Q2: Another Solid Report (NASDAQ:MASS) - Seeking Alpha
908 Devices Inc (MASS) (Q2 2026) Earnings Call Highlights: Stron - GuruFocus
908 Devices Inc (MASS) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance UK
908 Devices (NASDAQ:MASS) Director Sells $85,261.26 in Stock - MarketBeat
908 Devices (MASS) CEO Knopp sells 149K shares, reports 541K held via trust - Stock Titan
908 Devices (MASS) director Brown sells 17,800 shares in Rule 10b5-1 trades - Stock Titan
MASS Maintains Buy Rating by Stifel -- Price Target Raised to $1 - GuruFocus
908 Devices: Mission Critical Devices Drive Growth (NASDAQ:MASS) - Seeking Alpha
MASS Maintained by Roth Capital -- Price Target Raised to $13.00 - GuruFocus
908 Devices at Canaccord Genuity growth conference: growth, cash and new bets - Investing.com Canada
908 Devices at canaccord growth conference: cash, grants and new products - Investing.com Canada
Stifel raises 908 Devices stock price target on Q2 beat, guidance - Investing.com
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference - 01net
Roth MKM Maintains 908 Devices(MASS.US) With Buy Rating, Raises Target Price to $13 - Moomoo
Stifel Maintains 908 Devices(MASS.US) With Buy Rating, Raises Target Price to $12 - Moomoo
908 Devices earnings missed by $0.17, revenue topped estimates - Investing.com Nigeria
Earnings call transcript: 908 Devices tops revenue forecast in Q2 2026 - Investing.com UK
908 Devices Inc Stock (MASS) Financials Data
Revenue
Net Income
Cash Flow
EPS
908 Devices Inc Stock (MASS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Griffith Joseph H. IV | Chief Financial Officer |
Aug 25 '26 |
Sale |
10.95 |
11,459 |
125,476 |
121,497 |
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):